Diagnostic Value of Surveillance 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma After Curative Therapy
Sign Up to like & getrecommendations! Published in 2024 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000005639
Abstract: Purpose This study aimed to evaluate the diagnostic performance of surveillance FDG PET/CT for detection of clinically unexpected recurrent disease or second primary malignancy in head and neck squamous cell carcinoma (HNSCC) patients who underwent… read more here.
Keywords: value; fdg pet; surveillance fdg; surveillance ... See more keywords
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P)
Sign Up to like & getrecommendations! Published in 2024 at "BJU International"
DOI: 10.1111/bju.16314
Abstract: Older men (aged ≥75 years) with high risk, non‐metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs life and improves health‐related quality of life… read more here.
Keywords: therapy; men aged; non metastatic; high risk ... See more keywords
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13766
Abstract: Entecavir (ETV) and Tenofovir disoproxil fumarate (TDF) are the first‐line drugs for the treatment of chronic hepatitis B virus (HBV). However, the impact of these two antiviral agents on the outcome of HBV‐related hepatocellular carcinoma… read more here.
Keywords: tdf; curative therapy; recurrence; chronic hepatitis ... See more keywords
Planning Mental Health and Social Support Prescreening Assessments for Adult Sickle Cell Disease Patients: Evaluating Readiness for Curative Therapy
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-200954
Abstract: Background: The foundation for the accreditation for cellular therapy (FACT) has published standards for hematopoietic cell therapy. The NIH Cure Sickle Cell Initiative (CureSCi) [i] has highlighted how the mental health and social readiness of… read more here.
Keywords: mental health; process; therapy; curative therapy ... See more keywords
Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14030632
Abstract: Simple Summary Non-small cell lung cancer (NSCLC) patients are at considerable risk of recurrence or second primary cancer (SPC) after curative therapy. The utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) surveillance to detect… read more here.
Keywords: surveillance; pet; therapy; curative therapy ... See more keywords
Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm13030397
Abstract: Background: Hepatocellular carcinoma (HCC) tends to recur after curative treatment. This study aimed to identify the clinical factors associated with HCC recurrence after initial curative therapy. Methods: We retrospectively included patients with early stage HCC… read more here.
Keywords: hepatocellular carcinoma; hcc recurrence; curative therapy; recurrence ... See more keywords